Illumina's Cancer Sequencing Service 'Strategically Important' as NGS Moves to Clinic | GenomeWeb

By Monica Heger

This story has been updated from a version published Feb. 17 to correct pricing information.

Illumina has launched a cancer genome sequencing service that will incorporate an "optimized combined caller method" for improved accuracy of variant calls in heterogenous tumor samples.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.